{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:13:52Z","timestamp":1789982032781,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1032254"],"award-info":[{"award-number":["1032254"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12889-017-4959-3","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T11:45:20Z","timestamp":1513683920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-0703","authenticated-orcid":false,"given":"Robyn","family":"Eakle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Jarrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"4959_CR1","volume-title":"Global AIDS Update","author":"UNAIDS","year":"2016","unstructured":"UNAIDS. Global AIDS Update. 2016."},{"key":"4959_CR2","doi-asserted-by":"crossref","unstructured":"Hoffman S, Mantell J, Exner T, Stein Z. The Future of the Female Condom. Int Fam Plan Perspect [Internet]. 2004 Sep [cited 2013 Jun 24];30(3). Available from: https:\/\/www.guttmacher.org\/pubs\/journals\/3013904.html","DOI":"10.1363\/3013904"},{"issue":"6","key":"4959_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/13691050410001701948","volume":"6","author":"A Kaler","year":"2004","unstructured":"Kaler A. The future of female-controlled barrier methods for HIV prevention: female condoms and lessons learned. Cult Health Sex. 2004;6(6):501\u201316.","journal-title":"Cult Health Sex"},{"issue":"2","key":"4959_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/0958923042000217819","volume":"13","author":"A Kaler","year":"2004","unstructured":"Kaler A. The female condom in North America: selling the technology of \u201cempowerment\u201d. J Gend Stud. 2004;13(2):139\u201352.","journal-title":"J Gend Stud"},{"issue":"2","key":"4959_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/QAI.0b013e318278ba1b","volume":"62","author":"P Izulla","year":"2013","unstructured":"Izulla P, McKinnon LR, Munyao J, Karanja S, Koima W, Parmeres J, et al. HIV postexposure prophylaxis in an urban population of female sex workers in Nairobi, Kenya. J Acquir Immune Defic Syndr 1999. 2013;62(2):220\u20135.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"4959_CR6","unstructured":"Young T, Arens FJ, Kennedy GE, Laurie JW, Rutherford GW. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2007 [cited 2016 Jun 23]. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD002835.pub3\/abstract ."},{"issue":"8900488, bmj, 1","key":"4959_CR7","doi-asserted-by":"publisher","first-page":"b515","DOI":"10.1136\/bmj.b515","volume":"338","author":"JC Kim","year":"2009","unstructured":"Kim JC, Askew I, Muvhango L, Dwane N, Abramsky T, Jan S, et al. Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study. BMJ. 2009;338(8900488, bmj, 101090866):b515.","journal-title":"BMJ"},{"key":"4959_CR8","unstructured":"Bryant J, Baxter L, Hird S. Non-occupational postexposure prophylaxis for HIV: a systematic review. Health Technol Assess Winch Engl. 2009 13(14):iii, ix\u2013x, 1-60."},{"issue":"12","key":"4959_CR9","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS Lond Engl. 2016;30(12):1973\u201383.","journal-title":"AIDS Lond Engl"},{"issue":"9883","key":"4959_CR10","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"key":"4959_CR11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of Tenofovir gel, an antiretroviral Microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168\u201374.","journal-title":"Science"},{"key":"4959_CR12","unstructured":"FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women [Internet]. [cited 2015 Jun 25]. Available from: http:\/\/www.croiconference.org\/sessions\/facts-001-phase-iii-trial-pericoital-tenofovir-1-gel-hiv-prevention-women"},{"key":"4959_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"4959_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"2","key":"4959_CR15","doi-asserted-by":"publisher","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One. 2014;9(2):e89118.","journal-title":"PLoS One"},{"key":"4959_CR16","unstructured":"Corneli A, Wang M, Agot K, Olang\u2019o L, Makatu S, Lombaard J, et al. The association between risk perception and adherence in the FEM-PrEP clinical trial. In Kuala Lumpur; 2013 [cited 2014 Apr 15]. Available from: http:\/\/pag.ias2013.org\/Abstracts.aspx?AID=3118"},{"key":"4959_CR17","doi-asserted-by":"publisher","DOI":"10.4135\/9781412985000","volume-title":"Meta-ethnography: synthesizing qualitative studies","author":"GW Noblit","year":"1988","unstructured":"Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. London: Sage Publications; 1988."},{"issue":"2","key":"4959_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1365-2648.2005.03380.x","volume":"50","author":"D Walsh","year":"2005","unstructured":"Walsh D, Downe S. Meta-synthesis method for qualitative research: a literature review. J Adv Nurs. 2005;50(2):204\u201311.","journal-title":"J Adv Nurs"},{"key":"4959_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-3156.2010.02510.x","volume":"15","author":"S Merten","year":"2010","unstructured":"Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Tropical Med Int Health. 2010;15:16\u201333.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"4959_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2458-13-220","volume":"13","author":"M Musheke","year":"2013","unstructured":"Musheke M, Ntalasha H, Gari S, Mckenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13(1):220.","journal-title":"BMC Public Health"},{"issue":"4","key":"4959_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0277-9536(02)00064-3","volume":"56","author":"R Campbell","year":"2003","unstructured":"Campbell R, Pound P, Pope C, Britten N, Pill R, Morgan M, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56(4):671\u201384.","journal-title":"Soc Sci Med"},{"issue":"7","key":"4959_CR22","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"4959_CR23","unstructured":"Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care [Internet]. [cited 2013 Mar 8]. Available from: http:\/\/www.york.ac.uk\/inst\/crd\/SysRev\/!SSL!\/WebHelp\/SysRev3.htm"},{"issue":"1","key":"4959_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13643-015-0096-1","volume":"4","author":"R Eakle","year":"2015","unstructured":"Eakle R, Jarrett C, Bourne A, Stadler J, Larson H. Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa. Syst Rev. 2015;4(1):111.","journal-title":"Syst Rev"},{"issue":"1","key":"4959_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.socscimed.2008.09.068","volume":"68","author":"A Malpass","year":"2009","unstructured":"Malpass A, Shaw A, Sharp D, Walter F, Feder G, Ridd M, et al. \u201cMedication career\u201d or \u201cmoral career\u201d? The two sides of managing antidepressants: a meta-ethnography of patients\u2019 experience of antidepressants. Soc Sci Med. 2009;68(1):154\u201368.","journal-title":"Soc Sci Med"},{"key":"4959_CR26","unstructured":"Gough D, Oliver S, Thomas J. An Introduction to Systematic Reviews. London: SAGE Publications Ltd.; 2012."},{"issue":"8","key":"4959_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/13691058.2010.507876","volume":"12","author":"M Gafos","year":"2010","unstructured":"Gafos M, Mzimela M, Sukazi S, Pool R, Montgomery C, Elford J. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929\u201342.","journal-title":"Cult Health Sex"},{"issue":"7","key":"4959_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/13691051003728599","volume":"12","author":"E Greene","year":"2010","unstructured":"Greene E, Batona G, Hallad J, Johnson S, Neema S, Tolley EE. Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Cult Health Sex. 2010;12(7):739\u201354.","journal-title":"Cult Health Sex"},{"key":"4959_CR29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/OLQ.0b013e3181812939","volume":"35","author":"GP Guest","year":"2008","unstructured":"Guest GP, Shattuck DMS, Johnson LMA, Akumatey BM, Kekawo Clarke EEMD, Chen P-LP, et al. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sex Transm Dis. 2008;35:1002\u20138.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"4959_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1521\/aeap.2012.24.1.54","volume":"24","author":"D Kacanek","year":"2012","unstructured":"Kacanek D, Dennis A, Sahin-Hodoglugil NN, Montgomery ET, Morar N, Mtetwa S, et al. A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2012;24(1):54\u201367.","journal-title":"AIDS Educ Prev Off Publ Int Soc AIDS Educ"},{"issue":"4","key":"4959_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/13691058.2014.963680","volume":"17","author":"S Lees","year":"2015","unstructured":"Lees S. Emergent HIV technology: urban Tanzanian women\u2019s narratives of medical research, microbicides and sexuality. Cult Health Sex. 2015;17(4):412\u201327.","journal-title":"Cult Health Sex"},{"issue":"6","key":"4959_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/13691051003736261","volume":"12","author":"CM Montgomery","year":"2010","unstructured":"Montgomery CM, Gafos M, Lees S, Morar NS, Mweemba O, Ssali A, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649\u201362.","journal-title":"Cult Health Sex"},{"issue":"7","key":"4959_CR33","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s10461-012-0215-0","volume":"16","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, von Mollendorf C, et al. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16(7):1775\u201386.","journal-title":"AIDS Behav"},{"issue":"1","key":"4959_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13691050701519730","volume":"10","author":"J Okal","year":"2008","unstructured":"Okal J, Stadler J, Ombidi W, Jao I, Luchters S, Temmerman M, et al. Secrecy, disclosure and accidental discovery: perspectives of diaphragm users in Mombasa. Kenya Cult Health Sex. 2008;10(1):13\u201326.","journal-title":"Kenya Cult Health Sex"},{"issue":"8","key":"4959_CR35","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1080\/09540121.2010.543879","volume":"23","author":"NN Sahin-Hodoglugil","year":"2011","unstructured":"Sahin-Hodoglugil NN, Montgomery E, Kacanek D, Morar N, Mtetwa S, Nkala B, et al. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care. 2011;23(8):1026\u201334.","journal-title":"AIDS Care"},{"key":"4959_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.socscimed.2014.03.021","volume":"110","author":"J Stadler","year":"2014","unstructured":"Stadler J, Delany-Moretlwe S, Palanee T, Rees H. Hidden harms: Women\u2019s narratives of intimate partner violence in a microbicide trial. South Africa Soc Sci Med. 2014;110:49\u201355.","journal-title":"South Africa Soc Sci Med"},{"issue":"1","key":"4959_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/13691058.2010.511270","volume":"13","author":"J Stadler","year":"2011","unstructured":"Stadler J, Saethre E. Blockage and flow: intimate experiences of condoms and microbicides in a south African clinical trial. Cult Health Sex. 2011;13(1):31\u201344.","journal-title":"Cult Health Sex"},{"issue":"6","key":"4959_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09540120701693974","volume":"20","author":"CM Montgomery","year":"2008","unstructured":"Montgomery CM, Lees S, Stadler J, Morar NS, Ssali A, Mwanza B, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733\u201340.","journal-title":"AIDS Care"},{"key":"4959_CR39","doi-asserted-by":"crossref","unstructured":"van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc [Internet]. 2014 Sep 8 [cited 2016 Sep 22];17(3Suppl 2). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4163995\/","DOI":"10.7448\/IAS.17.3.19146"},{"issue":"5","key":"4959_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/13625187.2012.694147","volume":"17","author":"T Mathenjwa","year":"2012","unstructured":"Mathenjwa T, Maharaj P. \u201cFemale condoms give women greater control\u201d: a qualitative assessment of the experiences of commercial sex workers in Swaziland. Eur J Contracept Reprod Health Care Off J Eur Soc Contracept. 2012;17(5):383\u201392.","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"7","key":"4959_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/13691058.2012.697191","volume":"14","author":"ET Montgomery","year":"2012","unstructured":"Montgomery ET, Chidanyika A, Chipato T, van der Straten A. Sharing the trousers: gender roles and relationships in an HIV-prevention trial in Zimbabwe. Cult Health Sex. 2012;14(7):795\u2013810.","journal-title":"Cult Health Sex"},{"key":"4959_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6874-14-88","volume":"14","author":"B Magazi","year":"2014","unstructured":"Magazi B, Stadler J, Delany-Moretlwe S, Montgomery E, Mathebula F, Hartmann M, et al. Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa. BMC Womens Health. 2014;14:88.","journal-title":"BMC Womens Health"},{"issue":"5","key":"4959_CR43","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","volume":"19","author":"ET Montgomery","year":"2015","unstructured":"Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, et al. Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of \u201cunderstanding.\u201d. AIDS Behav. 2015;19(5):784\u201393.","journal-title":"AIDS Behav"},{"issue":"5","key":"4959_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/13691050903556316","volume":"12","author":"N Abrahams","year":"2010","unstructured":"Abrahams N, Jewkes R. Barriers to post exposure prophylaxis (PEP) completion after rape: a south African qualitative study. Cult Health Amp Sex. 2010;12(5):471\u201384.","journal-title":"Cult Health Amp Sex"},{"issue":"3","key":"4959_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/OLQ.0b013e31815abaa2","volume":"35","author":"FMTF Behets","year":"2008","unstructured":"Behets FMTF, Van Damme K, Turner AN, Rabenja NL, Ravelomanana NLR, Raharinivo MSM, et al. Evidence-based planning of a randomized controlled trial on diaphragm use for prevention of sexually transmitted infections. Sex Transm Dis. 2008;35(3):238\u201342.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"4959_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10461-013-0676-9","volume":"18","author":"M Gafos","year":"2014","unstructured":"Gafos M, Pool R, Mzimela MA, Ndlovu HB, McCormack S, Elford J. The implications of post-coital Intravaginal cleansing for the introduction of vaginal Microbicides in South Africa. AIDS Behav. 2014;18(2):297\u2013310.","journal-title":"AIDS Behav"},{"issue":"4","key":"4959_CR47","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/jwh.2009.1576","volume":"19","author":"G Guest","year":"2010","unstructured":"Guest G, Shattuck D, Johnson L, Akumatey B, Clarke EEK, Chen P-L, et al. Acceptability of PrEP for HIV prevention among women at high risk for HIV. J Womens Health 2002. 2010;19(4):791\u20138.","journal-title":"J Womens Health 2002"},{"key":"4959_CR48","unstructured":"International Partnership for Microbicides. Women and the need for microbicdes [Internet]. [cited 2016 Jun 23]. Available from: http:\/\/r4d.dfid.gov.uk\/PDF\/Outputs\/Microbicides\/WomenNeedforMicrobicides_ENGLISH_Jan2011.pdf"},{"key":"4959_CR49","unstructured":"WHO | Microbicides [Internet]. WHO. [cited 2016 Jun 23]. Available from: http:\/\/www.who.int\/hiv\/topics\/microbicides\/microbicides\/en\/"},{"key":"4959_CR50","unstructured":"UNAIDS. Microbicides: why are they significant? (Part 1) [Internet]. [cited 2016 Jun 23]. Available from: http:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2008\/february\/20080220microbicideswhyaretheysignificantpa"},{"key":"4959_CR51","unstructured":"Linda-Gail Bekker, James Hughes, Rivet Amico, Surita Roux, Craig Hendrix, Peter L. Anderson, et al. HPTN 067\/ADAPT Cape Town: A Comparison of Daily and Nondaily PrEP Dosing in African Women. In Seattle, WA; 2015 [cited 2017 Sep 21]. Available from: http:\/\/www.croiconference.org\/sessions\/hptn-067adapt-cape-town-comparison-daily-and-nondaily-prep-dosing-african-women"},{"key":"4959_CR52","doi-asserted-by":"crossref","unstructured":"Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J Int AIDS Soc. 2016;19(1). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4887458\/ . Date Accessed 27 Sept 2017.","DOI":"10.7448\/IAS.19.1.20875"},{"issue":"16","key":"4959_CR53","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"DER VAN","year":"2015","unstructured":"VAN DER, STRATEN A, MONTGOMERY ET, MUSARA P, ETIMA J, NAIDOO S, LABORDE N, et al. Disclosure of pharmacokinetic drug results to understand nonadherence: results from a qualitative study. AIDS Lond Engl. 2015;29(16):2161\u201371.","journal-title":"AIDS Lond Engl"},{"key":"4959_CR54","unstructured":"Chicago PrEP Working Group. Powered by AIDS Foundation of Chicago. PrEP4Love. One Pill. Once a Day. Protect Against HIV. [Internet]. PrEP4Love.com . 2016 [cited 2017 Sep 21]. Available from: http:\/\/prep4love.com\/"},{"issue":"3","key":"4959_CR55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/QAI.0000000000000607","volume":"69","author":"AD Kashuba","year":"2015","unstructured":"Kashuba AD, Gengiah TN, Werner L, Yang K-H, White NR, Karim QA, et al. Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness. J Acquir Immune Defic Syndr 1999. 2015;69(3):264\u20139.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"1","key":"4959_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/jiw077","volume":"214","author":"ML Cottrell","year":"2016","unstructured":"Cottrell ML, Yang KH, Prince HMA, Sykes C, White N, Malone S, et al. A translational pharmacology approach to predicting outcomes of Preexposure prophylaxis against HIV in men and women using Tenofovir Disoproxil Fumarate with or without Emtricitabine. J Infect Dis. 2016;214(1):55\u201364.","journal-title":"J Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-017-4959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-017-4959-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-017-4959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T01:46:44Z","timestamp":1693360004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-017-4959-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4959"],"URL":"https:\/\/doi.org\/10.1186\/s12889-017-4959-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"12 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics approvals were sought for this work as it comprises a secondary analysis of published data. As such, individual participant consent was also not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of or competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"968"}}